NO20000122L - FremgangsmÕte for fremstilling av kalsiumpyruvater - Google Patents
FremgangsmÕte for fremstilling av kalsiumpyruvaterInfo
- Publication number
- NO20000122L NO20000122L NO20000122A NO20000122A NO20000122L NO 20000122 L NO20000122 L NO 20000122L NO 20000122 A NO20000122 A NO 20000122A NO 20000122 A NO20000122 A NO 20000122A NO 20000122 L NO20000122 L NO 20000122L
- Authority
- NO
- Norway
- Prior art keywords
- calcium
- pyruvates
- obesity
- preparation
- calcium pyruvates
- Prior art date
Links
- UZWMCCLZMHPPKW-UHFFFAOYSA-L calcium;2-oxopropanoate Chemical class [Ca+2].CC(=O)C([O-])=O.CC(=O)C([O-])=O UZWMCCLZMHPPKW-UHFFFAOYSA-L 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 2
- 208000008589 Obesity Diseases 0.000 abstract 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 abstract 2
- 235000020824 obesity Nutrition 0.000 abstract 2
- 239000000126 substance Substances 0.000 abstract 2
- 229930194542 Keto Natural products 0.000 abstract 1
- 230000002378 acidificating effect Effects 0.000 abstract 1
- 210000000577 adipose tissue Anatomy 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 159000000007 calcium salts Chemical class 0.000 abstract 1
- 235000015872 dietary supplement Nutrition 0.000 abstract 1
- 239000003085 diluting agent Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 150000002440 hydroxy compounds Chemical class 0.000 abstract 1
- 125000000468 ketone group Chemical group 0.000 abstract 1
- 230000002669 organ and tissue protective effect Effects 0.000 abstract 1
- 150000007524 organic acids Chemical class 0.000 abstract 1
- 235000005985 organic acids Nutrition 0.000 abstract 1
- 229940107700 pyruvic acid Drugs 0.000 abstract 1
- 239000002516 radical scavenger Substances 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/185—Saturated compounds having only one carboxyl group and containing keto groups
- C07C59/19—Pyruvic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/41—Preparation of salts of carboxylic acids
- C07C51/412—Preparation of salts of carboxylic acids by conversion of the acids, their salts, esters or anhydrides with the same carboxylic acid part
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Nutrition Science (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Catalysts (AREA)
- Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
Abstract
Det beskrives en fremgangsmåte for fremstilling av kalsiumpyruvater, hvorved man omsetter kalsiumsalter av organiske syrer eller sure organiske keto- eller hydroksyforbindelser med pyrodruesyre i temperaturområdet fra -20 til +120°C, eventuelt i nærvær av et fortynnings- eller oppløsningsmiddel. På denne måten er det mulig å fremstille kalsiumpyruvater med høy renhet som stort sett er vannfrie og som utviser en meget god lagringsstabilitet. Disse kalsiumpyruvatene anvendes for å øke utholdenheten og styrke i sporten, for å redusere vekts- og kroppsfett, så vel som beskyttelsessubstans for kroppsceller og vev, som substans for å inhibere radikaldannelsen så vel som radikalinnfangersubstans i kroppsceller og vev, innen medisin, ved behandlingen av fedme og overvekt og som emæringstilskudd.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19729786A DE19729786A1 (de) | 1997-07-11 | 1997-07-11 | Verfahren zur Herstellung von Calciumpyruvaten |
| US08/955,838 US5962734A (en) | 1997-07-11 | 1997-10-21 | Method of producing calcium pyruvates |
| PCT/EP1998/004089 WO1999002479A1 (de) | 1997-07-11 | 1998-07-02 | Verfahren zur herstellung von calciumpyruvaten |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20000122L true NO20000122L (no) | 2000-01-10 |
| NO20000122D0 NO20000122D0 (no) | 2000-01-10 |
Family
ID=26038228
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20000122A NO20000122D0 (no) | 1997-07-11 | 2000-01-10 | Fremgangsmåte for fremstilling av kalsiumpyruvater |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0993433B1 (no) |
| JP (1) | JP2002507998A (no) |
| AT (1) | ATE232195T1 (no) |
| AU (1) | AU725505B2 (no) |
| BR (1) | BR9810702A (no) |
| CA (1) | CA2296017A1 (no) |
| DK (1) | DK0993433T3 (no) |
| ES (1) | ES2189216T3 (no) |
| HU (1) | HUP0004638A3 (no) |
| IL (1) | IL133905A0 (no) |
| NO (1) | NO20000122D0 (no) |
| NZ (1) | NZ501771A (no) |
| PL (1) | PL337946A1 (no) |
| SK (1) | SK180799A3 (no) |
| TR (1) | TR200000018T2 (no) |
| TW (1) | TW404833B (no) |
| WO (1) | WO1999002479A1 (no) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITMI20010204A1 (it) * | 2001-02-02 | 2002-08-02 | Hunza Di Marazzita Maria Carme | Specialita' terapeutiche dotate di attivita' antiossidante ed in grado di controllare l'eccesso del peso corporeo |
| JP5406643B2 (ja) * | 2008-09-22 | 2014-02-05 | 日本合成化学工業株式会社 | α−オキソカルボン酸の金属塩の製造方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1465432A (fr) * | 1965-08-25 | 1967-01-13 | D Opochimiotherapie Lab | Nouveau sel de calcium et son procédé de préparation |
| US5294641A (en) * | 1991-11-27 | 1994-03-15 | Montefiore - University Hospital | Method for treating a medical patient for cardiac trauma |
| US5395822A (en) * | 1993-09-20 | 1995-03-07 | Izumi; Yukitoshi | Use of pyruvate to prevent neuronal degeneration associated with ischemia |
| US5612374A (en) * | 1994-02-14 | 1997-03-18 | Ronald T. Stanko | Inhibiting growth of mammary adenocarcinoma |
| US5480909A (en) * | 1994-08-08 | 1996-01-02 | University Of Pittsburgh Medical Center | Method for inhibiting generation of free-radicals |
| AT403916B (de) * | 1996-03-11 | 1998-06-25 | Chemie Linz Gmbh | Verfahren zur herstellung von calziumpyruvat und dessen hydraten |
| GB9611356D0 (en) * | 1996-05-31 | 1996-08-07 | Howard Alan N | Improvements in or relating to compositions containing Creatine, and other ergogenic compounds |
| US5716926A (en) * | 1996-07-26 | 1998-02-10 | Paxton K. Beale | Composition of pyruvate and protein and method for increasing protein concentration in a mammal |
| US5756469A (en) * | 1996-07-26 | 1998-05-26 | Beale; Paxton K. | Composition of pyruvate and anti-cortisol compounds and method for increasing protein concentration in a mammal |
-
1998
- 1998-06-11 TW TW087109308A patent/TW404833B/zh not_active IP Right Cessation
- 1998-07-02 AT AT98938682T patent/ATE232195T1/de not_active IP Right Cessation
- 1998-07-02 SK SK1807-99A patent/SK180799A3/sk unknown
- 1998-07-02 BR BR9810702-0A patent/BR9810702A/pt not_active Application Discontinuation
- 1998-07-02 PL PL98337946A patent/PL337946A1/xx unknown
- 1998-07-02 HU HU0004638A patent/HUP0004638A3/hu unknown
- 1998-07-02 TR TR2000/00018T patent/TR200000018T2/xx unknown
- 1998-07-02 CA CA002296017A patent/CA2296017A1/en not_active Abandoned
- 1998-07-02 ES ES98938682T patent/ES2189216T3/es not_active Expired - Lifetime
- 1998-07-02 NZ NZ501771A patent/NZ501771A/xx unknown
- 1998-07-02 WO PCT/EP1998/004089 patent/WO1999002479A1/de not_active Ceased
- 1998-07-02 EP EP98938682A patent/EP0993433B1/de not_active Expired - Lifetime
- 1998-07-02 DK DK98938682T patent/DK0993433T3/da active
- 1998-07-02 AU AU87312/98A patent/AU725505B2/en not_active Ceased
- 1998-07-02 IL IL13390598A patent/IL133905A0/xx unknown
- 1998-07-02 JP JP50809799A patent/JP2002507998A/ja active Pending
-
2000
- 2000-01-10 NO NO20000122A patent/NO20000122D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ATE232195T1 (de) | 2003-02-15 |
| DK0993433T3 (da) | 2003-05-26 |
| IL133905A0 (en) | 2001-04-30 |
| NZ501771A (en) | 2000-10-27 |
| ES2189216T3 (es) | 2003-07-01 |
| BR9810702A (pt) | 2000-08-08 |
| TR200000018T2 (tr) | 2000-07-21 |
| CA2296017A1 (en) | 1999-01-21 |
| SK180799A3 (en) | 2001-10-08 |
| JP2002507998A (ja) | 2002-03-12 |
| TW404833B (en) | 2000-09-11 |
| WO1999002479A1 (de) | 1999-01-21 |
| NO20000122D0 (no) | 2000-01-10 |
| HUP0004638A3 (en) | 2003-09-29 |
| AU725505B2 (en) | 2000-10-12 |
| PL337946A1 (en) | 2000-09-11 |
| HUP0004638A1 (hu) | 2001-04-28 |
| EP0993433A1 (de) | 2000-04-19 |
| AU8731298A (en) | 1999-02-08 |
| EP0993433B1 (de) | 2003-02-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4356183A (en) | Antihypertensive 4-thiazolidinecarboxylic acids (pyridyl derivatives) | |
| Tew et al. | Synthesis and characterization of phosphocitric acid, a potent inhibitor of hydroxylapatite crystal growth | |
| JP3090960B2 (ja) | クレアチン―ピルベート及びその製造方法 | |
| HUT72188A (en) | Inhibitors of farnesyl-protein transferase | |
| JPH0460986B2 (no) | ||
| PT2578574E (pt) | Derivado de dibenzilamina opticamente activo, e processo para a sua fabricação | |
| Marrano et al. | Synthesis and evaluation of novel dipeptide-bound 1, 2, 4-thiadiazoles as irreversible inhibitors of guinea pig liver transglutaminase | |
| de Macédo et al. | Synthesis of dipeptide-bound epoxides and α, β-unsaturated amides as potential irreversible transglutaminase inhibitors | |
| Wang et al. | Solubility equilibria in the uric acid–sodium urate–water system | |
| DK155732B (da) | Analogifremgangsmaade til fremstilling af aminosyrederivater | |
| IL133905A0 (en) | Method for producing calcium pyruvates | |
| US7511164B2 (en) | Creatine-fatty acids | |
| US6342631B1 (en) | Method of producing calcium pyruvates | |
| PT805817E (pt) | Derivados tiol com actividade inibidora da metalopeptidase | |
| NO152971B (no) | Analogifremgangsmaate for fremstilling av n-(1-metyl-2-pyrrolidinyl-metyl)-2,3-dimetoksy-5-metylsulfamoyl-benzamid og derivater derav. | |
| Goodyer et al. | Time-dependence and preliminary SAR studies in inhibition of nitric oxide synthase isoforms by homologues of thiocitrulline | |
| SU1491337A3 (ru) | Способ получени гетероциклических соединений | |
| US20210371459A1 (en) | Dimeric peptide inhibitors of apoptosis proteins | |
| SU770062A1 (ru) | Этиловый эфир -этилдибутилоксивариановой кислоты,ОблАдАющий АНАльгЕТичЕСКОй АКТиВНОСТью | |
| SU1078847A1 (ru) | 4-(3,3-Диметилтриазено)-N-октаноилбензолсульфамид, про вл ющий противовоспалительную активность | |
| RU911881C (ru) | N-(п-Сульфамоилфенил)-N @ -(2-оксиэтил)сукциндиамид, про вл ющий противовоспалительную активность | |
| SU1060106A3 (ru) | Способ получени оптически активных @ -меркаптоалканоиламинокислот | |
| Paik et al. | Effect of modification of inhibitory amino acids on arginase activity | |
| EP0507348B1 (en) | Superoxide dismutase derivatives | |
| NO831114L (no) | Fremgangsmaate for fremstilling av blodtrykkssenkende midler |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |